Literature DB >> 9052357

Pretreatment with aspirin and ticlopidine confers lower thrombogenic potential of radiofrequency catheter ablation.

A S Manolis1, V Vassilikos, T N Maounis, L Psarros, H Melita-Manolis, D Papatheou, A Haliassos, V Christopoulou-Cokkinou, D V Cokkinos.   

Abstract

In the present study we pretreated 31 patients undergoing radiofrequency catheter ablation (RFA) with combined aspirin and ticlopidine for 3 days before the procedure, whereas 37 patients did not receive pretreatment. D-dimer levels reflecting the thrombogenic potential of RFA were significantly lower in the pretreated group at each stage before, during, and after the procedure, whereas there were no significant differences between the 2 groups in the number of RFA lesions or duration of the procedure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052357     DOI: 10.1016/s0002-9149(96)00792-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins.

Authors:  Alan Bulava; Ludek Slavík; Martin Fiala; Petr Heinc; Marcela Skvarilova; Jan Lukl; Vera Krcová; Karel Indrák
Journal:  J Interv Card Electrophysiol       Date:  2004-06       Impact factor: 1.900

2.  Electrophysiological studies and radiofrequency ablations in children and adolescents with arrhythmia.

Authors:  Mariana Fernandez Simão; Matheus Nardi Rios; Tiago Luiz Luz Leiria; Marcelo Lapa Kruse; Leonardo Martins Pires; Roberto Tofani SantAnna; Gustavo Glotz de Lima
Journal:  Arq Bras Cardiol       Date:  2014-11-04       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.